CACNA1H and cancer: Synthesis and testing of novel compounds resulted in the inhibition of Ca++ influx and the concomitant stereoselective inhibition of cell proliferation in cancer cells expressing CaV3.2, but not those devoid of CaV3.2 expression [92].